The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.
Search or browse funded studies
Previously funded studies appear chronologically, with the most recent appearing first.
-
Research Grant Supplement, 2014PERK Signaling in Parkinson’s Disease Progression
Promising Outcomes of Original Grant:
The original study validated the role of PERK (protein kinase RNA-like endoplasmic reticulum kinase) signaling in the progression of Parkinson’s disease (PD). We... -
Rapid Response Innovation Awards, 2014Optogenetics-based, Photo-switchable Model of Parkinson’s Disease for Drug Screening
Objective/Rationale:
Neurodegeneration has proven notoriously difficult to study. The main barrier to progress has been the challenging, heterogeneous nature of brain tissue. Optogenetics is a... -
Research Grant Supplement, 2014GluN2D Antagonism in the Subthalamic Nucleus for the Treatment of Parkinsonism
Promising Outcomes of Original Grant:
The goal of the original grant was to identify new chemical compounds that block specific types of receptors for the neurotransmitter glutamate and test whether... -
Rapid Response Innovation Awards, 2014Motor Proteins as Novel Drug Targets of Disease-modifying Treatments for Parkinson’s Disease
Objective/Rationale:
More and more research suggests that part of the cellular quality control mechanism, which degrades abnormal proteins or damaged parts of the cell, is defective in Parkinson’s... -
Research Grant, 2014Probing Nurr1 Expression in Parkinson’s Disease
Objective/Rationale:
Impaired function of the hormone receptor Nurr1 might contribute to the pathogenesis of Parkinson’s disease (PD) and is an active target for novel therapeutics. Previous studies... -
Rapid Response Innovation Awards, 2014Potential of Cell-permeable Parkin Proteins as a Treatment for Parkinson’s Disease
Objective/Rationale:
Parkin is an enzyme that protects cells, including neurons, from damage. Mutations in parkin can lead to loss of neurons and contribute to Parkinson’s disease (PD). We plan to...
Apply for a Grant
Our funding programs support basic, translational and clinical research from academia and industry.